# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T02:58:55.987362
**Route:** Direct Google API + PDF
**Tokens:** 28718 in / 938 out
**Response SHA256:** ed0d031b42fe8797

---

I have reviewed the draft paper for fatal errors that would preclude submission to a journal.

**FATAL ERROR 1: Data-Design Alignment**
- **Location:** Table 1 (page 10) and Table 12 (page 53)
- **Error:** The empirical design for the 2024 adoption cohort is impossible. Table 12 lists 5 states (AK, NE, NV, TX, UT) as adopting in 2024. Table 1 defines the treatment timing for this cohort as "e=0" in the 2024 survey year. However, the ACS 1-year PUMS (the data source) measures insurance "at the time of the interview" and income/fertility over the "past 12 months." A woman interviewed in early 2024 reporting a birth in 2023 would be coded as "treated" (e=0) for a policy that may not have existed yet or was only active for a few weeks. The paper notes this on page 9 ("respondents interviewed early in 2024 may be reporting on a period before the policy was active") but still includes them as the "treated" group for 2024.
- **Fix:** Either drop the 2024 adoption cohort from the treatment group (treating them as controls/not-yet-treated) or exclude the 2024 survey year, as the data does not provide a sufficient "post-treatment" window for these states.

**FATAL ERROR 2: Completeness**
- **Location:** Table 3 (page 19)
- **Error:** Missing required regression results. Column 4 (Low-Income Medicaid) contains only the ATT for Panel A. Columns 5 and 6 (Low-Income Uninsured and Employer) appear to be missing entirely or were cut off during formatting. Additionally, Panel C (DDD) does not report the N (Observations) or the number of clusters specific to that subsample, and the "Obs. (Panel D)" row is empty for column 4.
- **Fix:** Ensure all columns described in the headers (1-6) are fully populated with coefficients, SEs, CIs, and observation counts.

**FATAL ERROR 3: Internal Consistency**
- **Location:** Abstract (page 1) vs. Table 3 (page 19)
- **Error:** Numbers cited in the text do not match the evidence in the tables. The Abstract and Section 6.1 (page 17) cite a DDD CS-DiD estimate of "+0.99 pp (SE = 1.55 pp)". However, Table 3 (Panel C) reports this same estimate as "0.0099 (0.0153)". While these are mathematically equivalent (0.99% vs 0.0099), the standard error in the table (0.0153) does not match the text (0.0155). 
- **Fix:** Standardize units (either percentage points or decimals) across the paper and ensure every digit matches between the text and the tables.

**FATAL ERROR 4: Regression Sanity**
- **Location:** Table 4 (page 27)
- **Error:** Impossible values/Specification logic. The "Excluding PHE (2020–2022)" placebo test reports an ATT of -0.0218 with an SE of 0.0073. This is identical to the "Post-PHE (2017–19 + 2023–24)" result in the same table. It is mathematically impossible for a placebo test excluding 2020-2022 to yield the exact same result as a post-period analysis using 2023-2024 unless the data for 2020-2022 was already excluded from the latter, making the "placebo" a redundant copy of the main result rather than a test.
- **Fix:** Re-run the placebo test using only the "pre-period" years (e.g., using 2019 as a fake treatment year) to ensure it is actually testing the parallel trends assumption rather than restating the post-treatment result.

**ADVISOR VERDICT: FAIL**